Stock Information
Alnylam Pharmaceuticals Inc (ALNY)
Ticker Symbol: ALNY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $42,124.49 mil
Piotroski score: 5
PE Ratio: 141.571
EPS (TTM): 2.2451
Revenue (TTM): $27.25 M
Dividend Yield: N/A%
ROE: 90.35%
Latest News
-
Truist Securities Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $505
Mon, Apr 13, 2026 12:51 PM
-
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
Mon, Apr 13, 2026 9:19 AM
-
Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock?
Sun, Apr 12, 2026 6:38 PM
-
Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025
Thu, Apr 9, 2026 2:22 PM
-
Alnylam Cardiovascular Data Highlights Potential Upside In ATTR-CM And Hypertension
Wed, Apr 8, 2026 4:14 PM
Key Financials
Financial data not available
